Winch Advisory Services LLC Has $252,000 Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Share on StockTwits

Winch Advisory Services LLC lessened its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 7.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,308 shares of the financial services provider’s stock after selling 173 shares during the quarter. Winch Advisory Services LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $252,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CWM LLC increased its stake in shares of iShares Nasdaq Biotechnology ETF by 47.9% during the first quarter. CWM LLC now owns 9,742 shares of the financial services provider’s stock worth $1,089,000 after acquiring an additional 3,156 shares during the period. Mercer Global Advisors Inc. ADV acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the first quarter worth about $258,000. Cooper Haims Advisors LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the first quarter worth about $830,000. Pinnacle Advisory Group Inc. acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the first quarter worth about $227,000. Finally, Great Valley Advisor Group Inc. acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the first quarter worth about $201,000. 74.36% of the stock is owned by institutional investors.

Shares of iShares Nasdaq Biotechnology ETF stock traded down $2.68 on Friday, reaching $102.41. 3,269,024 shares of the stock were exchanged, compared to its average volume of 2,646,289. iShares Nasdaq Biotechnology ETF has a 1-year low of $89.01 and a 1-year high of $122.97. The business has a fifty day moving average price of $105.55 and a two-hundred day moving average price of $107.56.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: What are different types of coverage ratios?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell
Playa Hotels & Resorts  Upgraded at Zacks Investment Research
Playa Hotels & Resorts Upgraded at Zacks Investment Research


 
© 2006-2019 Zolmax.